NextCell Pharma AB

NEW
OSTO:NXTCL (Sweden)  
kr 1.102 -0.078 (-6.61%) Aug 24
At Loss
P/B:
2.43
Market Cap:
kr 122.75M ($ 12.92M)
Enterprise V:
kr 96.72M ($ 10.18M)
Volume:
445.54K
Avg Vol (2M):
350.07K
Trade In:
Volume:
445.54K
At Loss
Avg Vol (2M):
350.07K

NextCell Pharma AB (OSTO:NXTCL) Dividend

NextCell Pharma AB (OSTO:NXTCL) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -36.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSTO:NXTCL Dividend

Does NextCell Pharma AB (OSTO:NXTCL) pay a dividend?

NextCell Pharma AB (OSTO:NXTCL) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't NextCell Pharma AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. NextCell Pharma AB has returned capital to shareholders via buybacks at a rate of -36.8% over the past 3 years.

What are dividend-paying alternatives to NextCell Pharma AB?

For dividend-paying alternatives in NextCell Pharma AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.